Dr Catrin Plumpton

Research Fellow in Pharmacoeconomics

Contact info

Catrin is a Research Fellow in pharmacoeconomics at the Centre for Health Economics and Medicines Evaluation, with a background in mathematics and computing. Her main research focus and interests include cost effectiveness modelling and methodology.

Catrin holds an MMath degree and an MSc in Computer Systems from the University of Wales, Bangor, and completed her PhD on classification methods for fMRI data in 2011. Catrin joined CHEME in 2010 as a Research Officer in Medical Statistics. Her initial projects were the ‘ABC project’, a European funded FP7 study of adherence to medications where she was responsible for developing methodology to handle missing survey data, and a discrete choice experiment study of preferences for Stroke services in North Wales.

Catrin has since worked on several economic modelling projects in the area of epilepsy and pharmacogenetics, and has supervised post-graduate health economic students in the fields of orphan drugs and pharmacogenetics. Catrin is currently health economist for randomised controlled trials of medications for epilepsy, acute pancreatitis, and postpartum haemorrhage.

Contact Info

Catrin is a Research Fellow in pharmacoeconomics at the Centre for Health Economics and Medicines Evaluation, with a background in mathematics and computing. Her main research focus and interests include cost effectiveness modelling and methodology.

Catrin holds an MMath degree and an MSc in Computer Systems from the University of Wales, Bangor, and completed her PhD on classification methods for fMRI data in 2011. Catrin joined CHEME in 2010 as a Research Officer in Medical Statistics. Her initial projects were the ‘ABC project’, a European funded FP7 study of adherence to medications where she was responsible for developing methodology to handle missing survey data, and a discrete choice experiment study of preferences for Stroke services in North Wales.

Catrin has since worked on several economic modelling projects in the area of epilepsy and pharmacogenetics, and has supervised post-graduate health economic students in the fields of orphan drugs and pharmacogenetics. Catrin is currently health economist for randomised controlled trials of medications for epilepsy, acute pancreatitis, and postpartum haemorrhage.

View graph of relations